Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address…